SGMT 8-K 2026-09-30
Sagimet Biosciences Inc. (SGMT) 8-K dated 2026-09-30 — accession 0001193125-26-408224.
Sagimet Biosciences Inc. (SGMT) is a biotechnology company listed on NASDAQ.
Sagimet Biosciences Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-408224.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
Not investment advice. The SGMT SEC hub lists recent forms. The stock page is the research view.